Organigram Holdings Statistics

Total Valuation

Organigram Holdings has a market cap or net worth of CAD 284.51 million. The enterprise value is 212.47 million.

Market Cap	284.51M
Enterprise Value	212.47M

Important Dates

The next estimated earnings date is Monday, February 10, 2025.

Earnings Date	Feb 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Organigram Holdings has 128.16 million shares outstanding. The number of shares has increased by 24.68% in one year.

Current Share Class	n/a
Shares Outstanding	128.16M
Shares Change (YoY)	+24.68%
Shares Change (QoQ)	-35.94%
Owned by Insiders (%)	2.57%
Owned by Institutions (%)	5.75%
Float	92.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.32
PB Ratio	0.79
P/TBV Ratio	0.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.68
EV / Sales	1.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-247.34

Financial Position

The company has a current ratio of 4.92, with a Debt / Equity ratio of 0.01.

Current Ratio	4.92
Quick Ratio	2.71
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-5.19
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.93% and return on invested capital (ROIC) is -7.22%.

Return on Equity (ROE)	-14.93%
Return on Assets (ROA)	-6.31%
Return on Capital (ROIC)	-7.22%
Revenue Per Employee	177,997
Profits Per Employee	-50,601
Employee Count	898
Asset Turnover	0.45
Inventory Turnover	1.37

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.60% in the last 52 weeks. The beta is 1.06, so Organigram Holdings's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	-11.60%
50-Day Moving Average	2.20
200-Day Moving Average	2.37
Relative Strength Index (RSI)	46.01
Average Volume (20 Days)	228,280

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Organigram Holdings had revenue of CAD 159.84 million and -45.44 million in losses. Loss per share was -0.48.

Revenue	159.84M
Gross Profit	47.52M
Operating Income	-35.67M
Pretax Income	-45.44M
Net Income	-45.44M
EBITDA	-23.95M
EBIT	-35.67M
Loss Per Share	-0.48

Full Income Statement

Balance Sheet

The company has 107.57 million in cash and 4.46 million in debt, giving a net cash position of 103.11 million or 0.80 per share.

Cash & Cash Equivalents	107.57M
Total Debt	4.46M
Net Cash	103.11M
Net Cash Per Share	0.80
Equity (Book Value)	337.06M
Book Value Per Share	2.82
Working Capital	208.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.87 million and capital expenditures -4.73 million, giving a free cash flow of -859,000.

Operating Cash Flow	3.87M
Capital Expenditures	-4.73M
Free Cash Flow	-859,000
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 29.73%, with operating and profit margins of -22.32% and -28.43%.

Gross Margin	29.73%
Operating Margin	-22.32%
Pretax Margin	-28.43%
Profit Margin	-28.43%
EBITDA Margin	-14.98%
EBIT Margin	-22.32%
FCF Margin	n/a

Dividends & Yields

Organigram Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.68%
Shareholder Yield	-24.68%
Earnings Yield	-21.49%
FCF Yield	-0.30%

Stock Splits

The last stock split was on July 7, 2023. It was a reverse split with a ratio of 0.25.

Last Split Date	Jul 7, 2023
Split Type	Reverse
Split Ratio	0.25

Scores

Organigram Holdings has an Altman Z-Score of 0.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.6
Piotroski F-Score	n/a